- Home
- CMLS vs APM Comparison
CMLS vs APM Comparison
Compare CMLS & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMLS
- APM
- Stock Information
- Founded
- CMLS 2002
- APM 2010
- Country
- CMLS United States
- APM United Kingdom
- Employees
- CMLS N/A
- APM N/A
- Industry
- CMLS Broadcasting
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- CMLS Consumer Discretionary
- APM Health Care
- Exchange
- CMLS Nasdaq
- APM Nasdaq
- Market Cap
- CMLS 7.7M
- APM 6.7M
- IPO Year
- CMLS 1998
- APM 2018
- Fundamental
- Price
- CMLS $0.49
- APM $0.88
- Analyst Decision
- CMLS
- APM
- Analyst Count
- CMLS 0
- APM 0
- Target Price
- CMLS N/A
- APM N/A
- AVG Volume (30 Days)
- CMLS 453.3K
- APM 27.5K
- Earning Date
- CMLS 05-02-2025
- APM 04-29-2025
- Dividend Yield
- CMLS N/A
- APM N/A
- EPS Growth
- CMLS N/A
- APM N/A
- EPS
- CMLS N/A
- APM 0.00
- Revenue
- CMLS $827,076,000.00
- APM N/A
- Revenue This Year
- CMLS N/A
- APM $157,729.10
- Revenue Next Year
- CMLS $0.79
- APM N/A
- P/E Ratio
- CMLS N/A
- APM $242.56
- Revenue Growth
- CMLS N/A
- APM N/A
- 52 Week Low
- CMLS $0.41
- APM $0.46
- 52 Week High
- CMLS $3.34
- APM $11.19
- Technical
- Relative Strength Index (RSI)
- CMLS 41.72
- APM 42.47
- Support Level
- CMLS $0.42
- APM $0.85
- Resistance Level
- CMLS $0.51
- APM $1.00
- Average True Range (ATR)
- CMLS 0.08
- APM 0.07
- MACD
- CMLS 0.02
- APM 0.00
- Stochastic Oscillator
- CMLS 43.94
- APM 39.15
About CMLS Cumulus Media Inc.
Cumulus Media Inc is an audio-first media company delivering content to over a quarter billion people monthly whenever required. It is a radio broadcasting company combining high-quality local programming with iconic, nationally syndicated media, sports, and entertainment brands to deliver premium content choices to its customers and radio stations affiliated with the Westwood One network and numerous digital channels. The company's revenue is derived from Broadcast radio revenue, Digital revenue, and Other revenue.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.